Orca Capital AG 13D and 13G filings for Phio Pharmaceuticals Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-11 4:30 pm Sale | 2025-12-08 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Orca Capital AG | 538,707 4.900% | -161,714 (-23.09%) | Filing |
| 2025-11-24 4:05 pm Purchase | 2025-11-20 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Orca Capital AG | 700,421 6.500% | 291,160 (+71.14%) | Filing |
| 2025-11-12 06:10 am Sale | 2025-11-07 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Orca Capital AG | 409,261 4.900% | -390,739 (-48.84%) | Filing |
| 2025-11-06 5:00 pm Purchase | 2025-11-03 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Orca Capital AG | 800,000 9.800% | 519,358 (+185.06%) | Filing |
| 2025-08-07 4:05 pm Sale | 2025-08-04 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Orca Capital AG | 280,642 4.900% | -234,323 (-45.50%) | Filing |
| 2025-01-23 3:45 pm Purchase | 2024-12-19 | 13G | PHIO PHARMACEUTICALS CORP COM PHIO | Orca Capital AG | 514,965 9.900% | 514,965 (New Position) | Filing |